Breaking News

Takeda Opens R&D Cell Therapy Mfg. Facility in Boston

Will support expansion of next-generation clinical programs, including five collaborative oncology cell therapy programs entering trials.

By: Contract Pharma

Contract Pharma Staff

Takeda Pharmaceutical Co. Ltd. expanded its cell therapy manufacturing capabilities with the opening of a new 24,000 sq.-ft. R&D cell therapy manufacturing facility at its R&D headquarters in Boston, MA. The facility provides end-to-end research and development capabilities and will accelerate Takeda’s efforts to develop next-generation cell therapies, initially focused on oncology with potential to expand into other therapeutic areas. The R&D cell therapy manufacturing facility ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters